Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study.
Authors
Larkin, S E TJohnston, H E
Jackson, Tom R
Jamieson, D G
Roumeliotis, T I
Mockridge, C I
Michael, A
Manousopoulou, A
Papachristou, E K
Brown, Michael D
Clarke, Noel W
Pandha, H
Aukim-Hastie, C L
Cragg, M S
Garbis, S D
Townsend, Paul A
Affiliation
Cancer Sciences Unit, Southampton General Hospital, University of Southampton, Southampton SO16 6YDIssue Date
2016-09-29
Metadata
Show full item recordAbstract
Prostate cancer (PCa) is the most common male cancer in the United Kingdom and we aimed to identify clinically relevant biomarkers corresponding to stage progression of the disease.Citation
Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study. 2016 Br. J. CancerJournal
British Journal of CancerDOI
10.1038/bjc.2016.291PubMed ID
27685442Type
ArticleLanguage
enISSN
1532-1827ae974a485f413a2113503eed53cd6c53
10.1038/bjc.2016.291